The Enterprise Value as of September 2024 (TTM) for Fusion Pharmaceuticals Inc. (FUSN) is 1.87B

According to Fusion Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.87B. This represents a change of 145.90% compared to the average of 760.21M of the last 4 quarters.

Fusion Pharmaceuticals Inc. (FUSN) Historical Enterprise Value (quarterly & annually)

How has FUSN Enterprise Value performed in the past?

The mean historical Enterprise Value of Fusion Pharmaceuticals Inc. over the last ten years is 561.35M. The current 1.87B Enterprise Value has changed 33.20% with respect to the historical average. Over the past ten years (40 quarters), FUSN's Enterprise Value was at its highest in in the March 2024 quarter at 1.82B. The Enterprise Value was at its lowest in in the June 2020 quarter at -277554520.94.

Fusion Pharmaceuticals Inc. (FUSN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Fusion Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fusion Pharmaceuticals Inc. (FUSN) Average Enterprise Value

How has FUSN Enterprise Value performed in the past?

The current Enterprise Value of Fusion Pharmaceuticals Inc. (FUSN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Fusion Pharmaceuticals Inc. (FUSN) Enterprise Value vs. Peers

How is FUSN’s Enterprise Value compared to its peers?

Fusion Pharmaceuticals Inc.’s Enterprise Value is greater than Bicycle Therapeutics plc (497.43M), greater than Relmada Therapeutics, Inc. (70.33M), greater than RAPT Therapeutics, Inc. (32.52M), greater than NewAmsterdam Pharma Company N.V. (1.05B), greater than BioAtla, Inc. (24.10M), greater than Passage Bio, Inc. (44.87M), greater than PMV Pharmaceuticals, Inc. (40.92M), greater than Ikena Oncology, Inc. (46.38M), greater than Olema Pharmaceuticals, Inc. (662.53M), greater than Spero Therapeutics, Inc. (12.49M), greater than Bolt Biotherapeutics, Inc. (37.47M), greater than Coherus BioSciences, Inc. (281.96M), less than Gracell Biotechnologies Inc. (5.45B), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Keros Therapeutics, Inc. (1.58B), less than Janux Therapeutics, Inc. (2.16B), greater than Fennec Pharmaceuticals Inc. (131.47M), greater than Edgewise Therapeutics, Inc. (1.60B), less than Harmony Biosciences Holdings, Inc. (1.92B),

Build a custom stock screener for Fusion Pharmaceuticals Inc. (FUSN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fusion Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fusion Pharmaceuticals Inc. (FUSN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fusion Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.